Labcorp to Speak at the Morgan Stanley 23rd Annual Global Healthcare Conference
LHBURLINGTON, N.C., Aug. 27, 2025 /PRNewswire/ -- Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, announced today that members of the executive management team will participate in a fireside chat at the Morgan Stanley 23rd Annual Global Healthcare...
Labcorp Launches First FDA-Cleared Blood Test for Alzheimer's Disease
LHLumipulse® pTau-217/Beta Amyloid 42 Ratio now available nationwide through Labcorp BURLINGTON, N.C., Aug. 18, 2025 /PRNewswire/ -- Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, announced today the availability of the Lumipulse® pTau-217/Beta...
Predictive Oncology Develops 3D Organoid Models Exclusively For Labcorp, Including Human And Rat Model
LHWhat 8 Analyst Ratings Have To Say About Labcorp Hldgs
LHMorgan Stanley Maintains Overweight on Labcorp Hldgs, Raises Price Target to $283
LHLabcorp Expands Oncology Portfolio With New Tests For Solid And Blood Cancers; Reveals Expansion Of Capabilities To OmniSeq INSIGHT
LHTruist Securities Maintains Buy on Labcorp Hldgs, Raises Price Target to $290
LHAnalyst Expectations For Labcorp Hldgs's Future
LHPiper Sandler Maintains Neutral on Labcorp Hldgs, Raises Price Target to $280
LHBarclays Maintains Equal-Weight on Labcorp Hldgs, Raises Price Target to $250
LHBaird Maintains Outperform on Labcorp Hldgs, Raises Price Target to $267
LHLabcorp Raises FY25 Adj EPS Guidance From $15.60-$16.40 To $15.70-$16.40 Vs $17.59 Estimate; Reaffirms Sales Guidance Of $13.88B-$14.05B Vs $14.58B Estimate
LHLaboratory Corp Q1 Adj. EPS $3.84 Misses $4.17 Estimate, Sales $3.35B Miss $3.48B Estimate
LHEarnings Preview: Laboratory Corp
LHLabcorp Announced Today The Expansion Of Its Precision Oncology Portfolio With Two Solutions
LHReported April 18, 2025: Labcorp Acquires Select Assets Of North Mississippi Health Services' Ambulatory Outreach Laboratory Business; No Financial Terms Disclosed
LHTruist Securities Maintains Buy on Labcorp Hldgs, Lowers Price Target to $274
LHBarclays Maintains Equal-Weight on Labcorp Hldgs, Lowers Price Target to $240
LHAssessing Labcorp Hldgs: Insights From 8 Financial Analysts
LHRedburn Atlantic Initiates Coverage On Labcorp Hldgs with Buy Rating, Announces Price Target of $276
LHLabcorp Reveals Nationwide Launch Of pTau-217/Beta Amyloid 42 Ratio, New Blood-based Biomarker Test To Aid In Diagnosis Of Alzheimer's Disease
LHLabcorp Will Acquire Select Assets Of Bioreference Health, A Wholly Owned Subsidiary Of Opko Health For $225M, Including $192.5M Payable At Closing And Up To $32.5M In An Earnout Based On Performance
LHWhat 10 Analyst Ratings Have To Say About Labcorp Hldgs
LHCitigroup Upgrades Labcorp Hldgs to Buy, Raises Price Target to $300
LHIs the Market Bullish or Bearish on Labcorp Hldgs?
LHLabcorp Announced Today The Clinical Availability Of Labcorp Plasma Completetm, A Circulating Tumor Dna (Ctdna)-based Comprehensive Genomic Profiling Solution For Patients With Advanced Solid Tumors
LHLabcorp Launches Liquid Biopsy Test to Help Personalize Cancer Treatment
LHLabcorp Finalized Its Acquisition Of Select Assets And Molecular Testing Location Of Lab Works, An Accredited Independent Clinical Laboratory Located In Birmingham, Alabama For An Undisclosed Amount
LHLabcorp Announced That Executive Vice President And CFO Glenn Eisenberg Will Retire From The Company And Julia Wang Will Join On December 2 As Executive Vice President And CFO
LHDeutsche Bank Maintains Hold on Laboratory Corp, Lowers Price Target to $265
LHCredit Suisse Maintains Outperform on Laboratory Corp, Lowers Price Target to $312
LHLaboratory Corp: Q1 Earnings Insights
LHLaboratory Corp (NYSE:LH) reported its Q1 earnings results on Thursday, April 28, 2022 at 06:45 AM.
Here's what investors need to know about the announcement.
Labcorp Raises, Narrows FY22 Adj. EPS Guidance From $17.25-$21.25 To $18.25-$21 vs $19.54 Estimate
LHLaboratory Corp Q1 EPS $6.11 Beats $5.98 Estimate, Sales $3.90B Miss $4.00B Estimate; Initiates $0.72/Share Qtr. Dividend
LH